Saving The Optic Nerve : Manipulating The Shp2-Caveolin Axis
Funder
National Health and Medical Research Council
Funding Amount
$546,395.00
Summary
Glaucoma is a leading cause of blindness with many patients experiencing progressive vision loss despite treatment. We propose to use gene therapy techniques to manipulate the signalling pathway of Brain Derived Neurotrophic Factor and its receptor, along with biochemical and functional approaches to understand the mechanisms of glaucoma mediated eye damage and to develop new therapeutic strategies.
Young Adult Myopia: Genetic And Environmental Associations
Funder
National Health and Medical Research Council
Funding Amount
$809,271.00
Summary
Myopia affects 80% of school leavers in the cities of East Asia, 45% of Asian Australian school leavers and is probably on the rise in European Australian adolescents. Increased levels of education and lack of time outdoors are known to increase the risk of myopia. We will examine 2,000 young adults to find the genes that interact with these risk factors. In addition to confirming when these risk factors are most important, identifying molecular pathways opens the avenue of new treatments.
Seeing Clearly: Examining The Consequences Of Glaucoma For The Human Brain
Funder
National Health and Medical Research Council
Funding Amount
$439,694.00
Summary
Glaucoma is a major cause of blindness. Many people are unaware of the resulting blind region (scotoma) and fail to get an eye test, allowing the disease to progress. This project aims to see how the brain ‘fills in’ the scotoma, and the effect of different scotoma types, using vision tests, brain imaging, and behavioural methods. The results will tell us whether the region around a scotoma helps or hinders the person's remaining vision, which is critical for activities such as driving.